Prosecution Insights
Last updated: October 04, 2026
Application No. 18/245,410

TISSUE GRASPING DEVICES AND RELATED METHODS

Non-Final OA §112
Filed
Mar 15, 2023
Priority
Mar 25, 2020 — provisional 62/994,575 +4 more
Examiner
LOPEZ, LESLIE ANN
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Medfree Inc.
OA Round
1 (Non-Final)
66%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allowance Rate
436 granted / 666 resolved
-4.5% vs TC avg
Strong +34% interview lift
Without
With
+34.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
42 currently pending
Career history
705
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
40.3%
+0.3% vs TC avg
§102
20.2%
-19.8% vs TC avg
§112
28.9%
-11.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 666 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . The first inventor to file provisions of the Leahy-Smith America Invents Act (AIA ) apply to any application for patent, and to any patent issuing thereon, that contains or contained at any time— (A) a claim to a claimed invention that has an effective filing date on or after March 16, 2013 wherein the effective filing date is: (i) if subparagraph (ii) does not apply, the actual filing date of the patent or the application for the patent containing a claim to the invention; or (ii) the filing date of the earliest application for which the patent or application is entitled, as to such invention, to a right of priority under 35 U.S.C. 119, 365(a), or 365(b) or to the benefit of an earlier filing date under 35 U.S.C. 120, 121, or 365(c); or (B) a specific reference under 35 U.S.C. 120 , 121, or 365(c), to any patent or application that contains or contained at any time a claim as defined in paragraph (A), above. Status of the Claims Claim(s) 1-3 and 21-37 is/are pending. Claim(s) 22-27 is/are withdrawn. Claim(s) 4-20 is/are canceled. Allowable Subject Matter Claim(s) 1-3 and 21-37 are allowable over the prior art and would be allowable if the below rejections are addressed. The following is a statement of reasons for the indication of allowable subject matter: The prior art lacks an endovascular heart valve repair system, a valve repair leaflet grasping device, bailout suture, and an inverter bar, where the bailout suture is looped through the lateral ends of the inverter bar, in combination with the remaining claimed features. Election/Restrictions Applicant’s election without traverse of Group I in the reply filed on 7/13/2026 is acknowledged. Claims 4-20 would have been withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Groups II-V, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 7/13/2026. However, Applicant has canceled claims 4-20. Applicant’s election of Species 1-3 and Species 2-1 in the reply filed on 7/13/2026 and 8/5/2026 is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (MPEP § 818.01(a)). Applicant has added new claims 21-37 in the reply on 7/13/2026 and remaining on 8/5/2026. Due to Applicant’s amendments, the following changes to the restriction requirement structure are necessary for Groups I-V. The above elected groups and species content are maintained as follows. Group A: endovascular heart valve repair systems Former claims 1-3, 7-11 Group B: methods for expelling valve leaflets from a valve repair leaflet grasping device Former claims 4-6 Group C: an endovascular heart valve prosthesis Former claims 12-16 Group D: a method for deploying an endovascular heart valve Former claims 17-20 Upon election of Group A, an election must be made from the following species of endovascular heart valve repair systems. Species A-1: an endovascular heart valve repair system of former claims 1-3 (former Group I) Secondary suture, #93, e.g. Figures 8D, 9A-B, 10A-B Current claims: 1-3, 21, 28-37 Species A-2: an endovascular heart valve repair system with a hub and a spacer of former claims 7-11 (former Group 3) Hub, no reference number, [00178], only instance in specification Figures 27-29 Spacer, #s 264, 268, 270, 272, 274, 276 Figures 25-26, 31-36, 52 (#352); Figures 27-29 Current Claims: 1, 21-37 Here, Applicant’s election covers Group A, Species A-1. Overall, new claims 22-27 have been withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Groups B-D, Species A-2, Species 1-1, 1-2, 1-4, 1-5, and Species 2-2, 2-3, 2-4, 2-5, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 7/13/2026 and 8/5/2026. Claim Objections Claims 32 and 36-37 are objected to because of the following informalities: Claim 32 recites “a dip or pot-hole or grove”, which should be “a dip a pot-hole or a groove”. Claim 36 recites “a distal expandable funnel, coil, or fan”, which should be “a distal expandable funnel, a coil, or a fan”. Claim 37 recites “and actuator rod-gripper”, which should be “and an actuator rod-gripper”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claim 37 is rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Claim 37 recites “a corresponding implant pair,” “an implant-rod,” and “an implant-gripper.” It is unclear if these are the same as the “a first pair of leaflet capture arms,” “a first inner arm,” and “a first outer arm” introduced in claim 1 or if they are additional elements as written. As written, the specification lacks support for a combination of an inner/outer arm pair and an implant rod/gripper pair. Therefore, the combination of these two pairs of elements is new matter. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-3, 28, 31, 33-34, and 37 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1, line 13 and Claim 28 each recites “valve leaflets”. It is unclear if these are the same or different than those introduced earlier in claim 1, line 2. For purposes of examination the Examiner considers this language to be “the coapting heart valve leaflets”. Claim 2 recites the limitation "the bailout suture loop". There is insufficient antecedent basis for this limitation in the claim. For purposes of examination the Examiner is interpreting the following in claim 1, line 12: “and looped through opposite lateral ends of the inverter bar, forming a bailout suture loop, so that two ends of the …”. Claim 3 recites "the bailout loop". There is insufficient antecedent basis for this limitation in the claim. For purposes of examination the Examiner is interpreting the following in claim 1, line 12: “and looped through opposite lateral ends of the inverter bar, forming a bailout suture loop, so that two ends of the …”. Further, for purposes of examination the Examiner considers this language to be “the bailout suture loop” to be consistent with claim 2. Claim 31 recites the limitation "the patient’s ventricle". There is insufficient antecedent basis for this limitation in the claim. For purposes of examination the Examiner notes this language is being interpreted as “a patient’s ventricle”. Claims 33 and 34 each recites “leaflets”. It is unclear if these are the same or different than those introduced earlier in claim 1. For purposes of examination the Examiner considers this language to be “the coapting heart valve leaflets”. Claim 37 recites “a corresponding implant pair,” “an implant-rod,” and “an implant-gripper.” It is unclear if these are the same as the “a first pair of leaflet capture arms,” “a first inner arm,” and “a first outer arm” introduced in claim 1. If these are the intended references, then the terms in claim 37 should be corrected to refer to the names used in claim 1. If they are different elements, then see 35 USC 112(a) rejection above. Claims(s) 21, 29-30, 32, and 35-36 is/are rejected as being dependent from a rejected claim. Relevant Prior Art US 2013/0066341 to Ketai, et al teaches a heart valve leaflet grasping device having bailout suture (e.g. Figures 18-19), but lacks an inverter bar distal of the grasping device. US 2006/0020275 to Goldfarb, et al teaches a heart valve leaflet grasping device having bailout suture (e.g. Figures 3, 18 A, 18B), but lacks an inverter bar distal of the grasping device and having the bailout suture through both ends. US 2004/0049207 to Goldfarb, et al teaches a heart valve leaflet grasping device having bailout suture and distal inverter bar (e.g. Figures 18, 48), but lacks the bailout suture through both ends of the inverter. US 2019/0021852 to Delgado, et al teaches a heart valve leaflet grasping device having bailout suture and distal inverter bar (e.g. Figures 13, 42-43), but lacks the bailout suture through both ends of the inverter. AU 2002/316473 A1 to Dell, et al teaches a valve leaflet repair device having an inverter bar with a suture through both of its lateral ends (e.g. Figure 11C), a gripping structure embodiment (e.g. Figures 17D, 21A), but lacks a combination of a gripping device, a bailout suture, and an inverter with the bailout suture looped through its ends. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LESLIE A LOPEZ whose telephone number is (571)270-7044. The examiner can normally be reached 8:30 AM - 5:30 PM, MST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, JERRAH EDWARDS can be reached at (408)918-7557. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LESLIE A LOPEZ/Primary Examiner, Art Unit 3774 9/1/2026
Read full office action

Prosecution Timeline

Mar 15, 2023
Application Filed
Jul 13, 2026
Response after Non-Final Action
Aug 05, 2026
Response Filed
Sep 08, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12740857
INTRAOCULAR LENS DESIGNS FOR IMPROVED STABILITY
5y 3m to grant Granted Sep 22, 2026
Patent 12721718
PRE-STRAINED STENT ELEMENTS
4y 2m to grant Granted Sep 01, 2026
Patent 12714584
STENT GRAFT WITH BRACKETING STENT CONFIGURATIONS
3y 10m to grant Granted Aug 25, 2026
Patent 12702545
PROSTHETIC VALVES, FRAMES AND LEAFLETS AND METHODS THEREOF
1y 4m to grant Granted Aug 11, 2026
Patent 12697217
DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION
3y 9m to grant Granted Aug 04, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
66%
Grant Probability
99%
With Interview (+34.3%)
3y 6m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 666 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month